Ramon has a distinguished track record in entrepreneurship, innovation, and executive management in the digital health and life sciences industries. Most recently, Ramon held the role of Chief Technology Officer and Vice President, Strategy for QIAGEN N.V., a global provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
While at QIAGEN, Ramon founded QIAGEN Digital Insights (QDI) to build on its acquisition of Ingenuity Systems for entry into the AI, data science, and informatics markets. Ramon led the effort to found a new business unit, reporting to the CEO, to spearhead and accelerate this market entry, and helped recruit the founding QDI leadership team. He subsequently defined and drove the market entry roadmap and technology and data strategy that ultimately delivered a portfolio of 30 data science products and services through internal R&D and external acquisitions. Ramon further led the development and commercialization of an award-winning AI-based precision medicine product line that successfully guided care of 1M+ patients, unlocked a data rights strategy that enabled QDI to expand into the real-world evidence market. QDI rapidly establishing QIAGEN as an acclaimed market leader in research and clinical informatics markets, and achieved investor recognition as one of QIAGEN’s “crown jewels” (JP Morgan, 2019).
Prior to QIAGEN, Ramon founded Ingenuity Systems out of Stanford University to use AI and data curation to unlock the value of the human genome. As founding CTO and SVP Research, Ramon drove the venture-funded development of an award-winning core technology platform, unique data assets, and growing product lines (including IPA - Ingenuity Pathway Analysis) that ultimately defined a new market segment around genome interpretation and systems biology. Through these efforts, Ingenuity established itself as a global leader in AI-driven genome interpretation, predictive drug discovery, and cloud-based data management for pharma, biotech, and life sciences enterprises. QIAGEN acquired Ingenuity in 2013 for $105M to serve as a cornerstone for its expansion into sequencing and software and data markets.
Prior to Ingenuity, Ramon held several technology leadership positions at Stanford Medicine, where he founded SUMMIT, the Stanford University Medical Media and Information Technologies lab, an innovation lab for digital approaches to medical education and clinical decision making. Ramon also serves as principal at Digital Alchemy, a consultancy specializing in innovation, product, business model and go-to-market strategies for digital health startups as well as digital transformation and tech+data strategy creation for life sciences, pharma/biotech, and diagnostics organizations.
Ramon received his Ph.D. and M.S. in Biomedical Data Sciences from Stanford Medical School, his B.S. in Computer Science from Stanford University, and a B.A. in English and French Literature from Stanford University. He holds dual citizenship (Swiss and American), speaks 4 languages, has authored numerous patents and publications, and advises and presents on digital health topics around the world.
William LaFontaine is a recognized leader in the areas of technology licensing, technology partnerships and intellectual property. In his current role as General Manager of Intellectual Property at IBM, Dr. LaFontaine and his team work at the intersection of Research, Business Units and Clients to accelerate market introduction of new technologies including Artificial Intelligence, Quantum Computing and Healthcare. Dr. LaFontaine is responsible for annually delivering over a billion dollars in joint development, technology transfer and patent licensing. In his 29-year career at IBM, Dr. LaFontaine has been the Chief Operating Officer for IBM’s Research division, General Manager of Global Technology Services in Middle East and Africa as well as General Manager of Worldwide Semiconductor and Technology sales.
Dr. Cheryl Martin founded her consulting firm, Harwich Partners, to engage public and private sector entities in designing and implementing solutions for complex problems, especially those related to energy, sustainability, urban development and technology adoption.
Previously she was a member of the Managing Board at the World Economic Forum where she was responsible for a range of business and innovation initiatives. Before this, Cheryl had served as the Acting Director of the US Department of Energy’s Advanced Research Projects Agency–Energy (ARPA-E). She was also the Deputy Director for Commercialization at the agency where she developed the Technology-to-Market program, which helps breakthrough energy technologies succeed in the marketplace. Prior to joining ARPA-E, Cheryl was an Executive in Residence with at Kleiner Perkins after a career with Rohm and Haas Company in roles ranging from technology development to finance and business management.
Cheryl serves as the chair of the Board for Sound Agriculture, an early-stage sustainable agriculture technology company, as well as on the Boards for Evergreen Climate Innovations (Chicago) and Elemental Excelerator (HI and CA). Cheryl is also on the Board of Queens Gambit Growth Corporation (GMBT), an ESG-focused SPAC. She received her PhD in organic chemistry from MIT.
Peter Tollman is Senior Partner Emeritus and Senior Advisor at Boston Consulting Group. He's also an adjunct professor at Columbia Business School and an advisor to several private equity firms and development-stage companies.
Previously, Peter was Managing Director and Senior Partner in BCG's Boston office. He led BCG's CEO Advisory Practice globally, served as global leader of BCG’s Biopharmaceutical Practice, and led its People and Organization Practice in the Americas. He was also a BCG Fellow, a prestigious thought-leadership post.
Over the course of his consulting career, Peter has served many leading firms across industries and around the globe and has counseled numerous CEOs. He specialized in strategy and organizational and operational effectiveness and has advised on numerous corporate transformations, restructurings and mergers.
Peter has authored a large number of publications, and has been a featured speaker at many corporate and industry events. He coauthored the book Six Simple Rules: How to Manage Complexity without Getting Complicated, detailing the transformational approach to improving organizational performance that he helped to pioneer.
Peter joined BCG in 1989. He was also founding managing director of a healthcare venture capital firm, MPM Capital. He is a board member of Tech Care for All and sits on the Board of Governors of the Jerusalem Academy of Music and Dance at the Hebrew University.
Peter received his PhD in engineering from the University of Cape Town, and his MBA with distinction from Columbia Business School.